Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Factors Associated With the Absence of Contraception at Women Seeking a Voluntary Termination of Pregnancy

31. januar 2022 oppdatert av: Centre Hospitalier Intercommunal Creteil

Factors Associated With the Absence of Contraception at the Time of Unplaned Pregnancy Among Women Seeking a Voluntary Termination of Pregnancy

The study will be offered to all women who are consultant for an abortion plan are seen in consultation at the orthogeny center where the study will be conducted. Of these 700 women, about 10% will not agree to participate in the study and 10% will not meet the inclusion criteria. Thus it's plane to include 560 patients in the study.

Studieoversikt

Status

Suspendert

Detaljert beskrivelse

In 1967, the Neuwirth law allowed women to control their fertility by establishing the right to contraception as a principle. Since then, they have continued to take ownership of the various contraceptive methods, which are regularly renewed.

Contraceptive coverage is important in France as it is estimated that 92% of women of childbearing age use a contraceptive method. The pill remains the most widely used method of contraception (36.5%), ahead of the intrauterine device (25.6%) condoms (15.5%) Several laws have been introduced from 1967 to today to facilitate access to sexual health care: screening for sexually transmitted infections, free provision of emergency contraception to minors, non-prescription delivery of emergency contraception, free consultation at a family planning and education center, voluntary termination of pregnancy 100%, reimbursement of condoms by social security.

Despite all the measures put in place, it is now clear that the number of unplanted pregnancies is decreasing slightly and the number of abortion has remained stable since 2001.

According to the latest literature data, several socio-demographic factors appear to play a role in the rate of use of voluntary termination of pregnancy., including age, socio-cultural level, marital and economic status and ethnic origin. All the more striking, it appears that while voluntary termination of pregnancy are mainly related to contraceptive failures, one third of them involve women who do not have contraception. According to the latest Ined survey, and in accordance with other data from the literature, the factors associated with the absence of contraceptive use are multiple: ignorance about fertility, family or cultural context, cost of contraceptive methods or lack of information related to them.

While these studies have looked at the reasons given by women for the lack of contraception, with little data on the characteristics of these women, particularly socio-demographics and their reproductive history and in particular in the context of unwanted pregnancy. This finding leads us to question the factors associated with the absence of contraception among women in demand of a voluntary termination of pregnancy.

Studietype

Observasjonsmessig

Registrering (Forventet)

560

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Villeneuve-Saint-Georges, Frankrike
        • CHI Villeneuve St Georges

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Hunn

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Protocol proposed to woman who wanted a voluntary termination of pregnancy

Beskrivelse

Inclusion Criteria:

  • woman of 18 years of age or older;
  • Being French-speaking;
  • request for a medical or instrumental voluntary termination of pregnancy
  • No opposition to participation in the protocol
  • Be affiliated with a social security plan

Exclusion Criteria:

  • desired pregnancy

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Association between absence of contraception and socio-demographic factors, characteristics of pregnancy abortion and medical follow-up
Tidsramme: 1 hour
Statistically significant association between the absence of contraception in patients consulting for a voluntary termination of pregnancy and socio-demographic factors, characteristics of voluntary termination of pregnancy abortion and characteristics related to medical follow-up
1 hour

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Prescription and dispensing of contraception
Tidsramme: 1 hour
Prevalence of patients informed about the prescription and dispensing of contraception including emergency contraception
1 hour
Existence of family planning centers
Tidsramme: 1 hour
Prevalence of patients informed about the existence of family planning centers
1 hour
Emergency contraception
Tidsramme: 1 hour
Prevalence of women who have used emergency contraception
1 hour
Price and reimbursement of condoms
Tidsramme: 1 hour
Prevalence of women informed about the price and reimbursement of condoms
1 hour
Knowledge of conception
Tidsramme: 1 hour
Estimate the percentage of women who thought they could get pregnant at the time of the intercourse that led to this pregnancy
1 hour
Fertile window
Tidsramme: 1 hour
Prevalence of women who use a method to track their fertile window
1 hour
Affection of fertility
Tidsramme: 1 hour
Estimate the percentage of women who think that contraception can affect their fertility
1 hour

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Forventet)

1. november 2022

Primær fullføring (Forventet)

1. november 2022

Studiet fullført (Forventet)

1. november 2022

Datoer for studieregistrering

Først innsendt

11. februar 2021

Først innsendt som oppfylte QC-kriteriene

31. mars 2021

Først lagt ut (Faktiske)

2. april 2021

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

1. februar 2022

Siste oppdatering sendt inn som oppfylte QC-kriteriene

31. januar 2022

Sist bekreftet

1. januar 2022

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • NOCONTRAIVG
  • 2021-A00298-33 (Annen identifikator: ID-RCB)

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Graviditet, uønsket

  • King's College Hospital NHS Trust
    European Association for the Study of the Liver
    Rekruttering
    Skrumplever, lever | HELLP syndrom | Intrahepatisk kolestase ved graviditet | Graviditetssykdom | AFLP - Acute Fatty Liver of Pregnancy
    Storbritannia
Abonnere